Literature DB >> 18833545

Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31)P magic angle spinning MRS of intact tissue.

Sonali S De Silva1, Geoffrey S Payne, Valerie Thomas, Paul G Carter, Thomas E J Ind, Nandita M deSouza.   

Abstract

The aim of this study was to determine the metabolic changes in the transition from pre-invasive to invasive cervical cancer using high-resolution magic angle spinning (HR-MAS) MRS. Biopsy specimens were obtained from women with histologically normal cervix (n = 5), cervical intraepithelial neoplasia (CIN; mild, n = 5; moderate/severe, n = 40), and invasive cancer (n = 23). (1)H HR-MAS MRS data were acquired using a Bruker Avance 11.74 T spectrometer (Carr-Purcell-Meiboom-Gill sequence; TR = 4.8 s; TE = 135 ms; 512 scans; 41 min acquisition). (31)P HR-MAS spectra were obtained from the normal subjects and cancer patients only (as acetic acid applied before tissue sampling in patients with CIN impaired spectral quality) using a (1)H-decoupled pulse-acquire sequence (TR = 2.82 s; 2048 scans; 96 min acquisition). Peak assignments were based on values reported in the literature. Peak areas were measured using the AMARES algorithm. Estimated metabolite concentrations were compared between patient diagnostic categories and tissue histology using independent samples t tests. Comparisons based on patient category at diagnosis showed significantly higher estimated concentrations of choline (P = 0.0001) and phosphocholine (P = 0.002) in tissue from patients with cancer than from patients with high-grade dyskaryosis, but no differences between non-cancer groups. Division by histology of the sample also showed increases in choline (P = 0.002) and phosphocholine (P = 0.002) in cancer compared with high-grade CIN tissue. Phosphoethanolamine was increased in cancer compared with normal tissue (P = 0.0001). Estimated concentrations of alanine (P = 0.01) and creatine (P = 0.008) were significantly reduced in normal tissue from cancer patients compared with normal tissue from non-cancer patients. The estimated concentration of choline was significantly increased in CIN tissue from cancer patients compared with CIN tissue from non-cancer patients (P = 0.0001). Estimated concentrations of choline-containing metabolites increased from pre-invasive to invasive cervical cancer. Concurrent metabolite depletion occurs in normal tissue adjacent to cancer tissue. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18833545     DOI: 10.1002/nbm.1302

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  11 in total

Review 1.  Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.

Authors:  Christopher Dietz; Felix Ehret; Francesco Palmas; Lindsey A Vandergrift; Yanni Jiang; Vanessa Schmitt; Vera Dufner; Piet Habbel; Johannes Nowak; Leo L Cheng
Journal:  NMR Biomed       Date:  2017-09-15       Impact factor: 4.044

Review 2.  Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.

Authors:  Kanchan Sonkar; Vinay Ayyappan; Caitlin M Tressler; Oluwatobi Adelaja; Ruoqing Cai; Menglin Cheng; Kristine Glunde
Journal:  NMR Biomed       Date:  2019-06-11       Impact factor: 4.044

3.  Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues.

Authors:  Bagganahalli S Somashekar; Pachiyappan Kamarajan; Theodora Danciu; Yvonne L Kapila; Arul M Chinnaiyan; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  J Proteome Res       Date:  2011-10-18       Impact factor: 4.466

Review 4.  MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.

Authors:  Kristine Glunde; Lu Jiang; Siver A Moestue; Ingrid S Gribbestad
Journal:  NMR Biomed       Date:  2011-07       Impact factor: 4.044

5.  Can nuclear magnetic resonance (NMR) spectroscopy reveal different metabolic signatures for lung tumours?

Authors:  Iola F Duarte; Cláudia M Rocha; António S Barros; Ana M Gil; Brian J Goodfellow; Isabel M Carreira; João Bernardo; Ana Gomes; Vitor Sousa; Lina Carvalho
Journal:  Virchows Arch       Date:  2010-10-13       Impact factor: 4.064

Review 6.  Cancer insights from magnetic resonance spectroscopy of cells and excised tumors.

Authors:  Marie-France Penet; Raj Kumar Sharma; Santosh Bharti; Noriko Mori; Dmitri Artemov; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2022-03-09       Impact factor: 4.478

7.  HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.

Authors:  Pratima Tripathi; Bagganahalli S Somashekar; M Ponnusamy; Amy Gursky; Stephen Dailey; Priya Kunju; Cheryl T Lee; Arul M Chinnaiyan; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  J Proteome Res       Date:  2013-06-18       Impact factor: 4.466

8.  Epithelial and stromal metabolite changes in the transition from cervical intraepithelial neoplasia to cervical cancer: an in vivo 1H magnetic resonance spectroscopic imaging study with ex vivo correlation.

Authors:  Sonali S De Silva; Geoffrey S Payne; Veronica A Morgan; Thomas E J Ind; John H Shepherd; Desmond P J Barton; Nandita M deSouza
Journal:  Eur Radiol       Date:  2009-03-04       Impact factor: 5.315

9.  Single-shot single-voxel lactate measurements using FOCI-LASER and a multiple-quantum filter.

Authors:  Geoffrey S Payne; Nandita M deSouza; Christina Messiou; Martin O Leach
Journal:  NMR Biomed       Date:  2015-04       Impact factor: 4.044

10.  Discrimination of Basal Cell Carcinoma from Normal Skin Tissue Using High-Resolution Magic Angle Spinning 1H NMR Spectroscopy.

Authors:  Je-Ho Mun; Heonho Lee; Dahye Yoon; Byung-Soo Kim; Moon-Bum Kim; Shukmann Kim
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.